Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Key Notes from ROTH presentation new info!

1. Four big funds have expressed interest in buying RXII shares at current market prices so that the company can advance its ophthalmology pipeline! The Board is currently in talks/deciding to go this route

2. Rxi in process of getting an additional phase 2 compound to the pipeline

3. Rxi in process of getting another patent for their technology added, probably bevasirinib patent protection

4. Middle of the year in 2014 we will see results of phase 2 hypertrophic scars midpoints 3 months after results. So no guess by CEO but I'm assuming may/june probably - may include pictures of placebo/RXI-109 to show difference

5. Macular degeneration has crowded space, but Rxi's sd-rxRNA would target both VEGF for gene knockdown and CTGF to heal wound of eye. Basically would accomplish both - two birds with one stone

6. Rxi in process of testing lucentis current therapy and combining it with RXI-109

7. PVR just need GLP toxicity study then RXII can file IND in 2nd half 2014 for PVR indication

8. More testing needed but close in silencing retinoblastoma for eye cancer in children under age 15

Things are looking good if anyone else has anything to add then please do so.